Thromboelastography in liver transplantation.
Kang
Y
Y
University of Pittsburgh School of Medicine, Pennsylvania, USA.
D000328:Adult; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000097:blood / Q000209:etiology* / Q000628:therapy; D001779:Blood Coagulation Factors / Q000032:analysis; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002648:Child; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005342:Fibrinolysis; D006493:Heparin / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism; D016031:Liver Transplantation / Q000009:adverse effects*; D016343:Monitoring, Intraoperative / Q000379:methods*; D010949:Plasma; D015427:Reperfusion Injury / Q000097:blood / Q000503:physiopathology / Q000628:therapy; D016037:Single-Blind Method; D013916:Thrombelastography; D010959:Tissue Plasminogen Activator / Q000378:metabolism
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D006493:Heparin; D010959:Tissue Plasminogen Activator